439
Participants
Start Date
December 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
December 31, 2014
NNRTI
NNRTI agents administered according to prescribing information; allowed NNRTIs include efavirenz (EFV), nevirapine, or rilpivirine.
FTC/TDF
FTC/TDF (200/300 mg) administered according to prescribing information
Stribild
Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate; E/C/F/TDF) (150/150/200/300 mg) STR administered orally once daily with food
Hôpitaux IRIS Sud, Brussels
Medical University of Vienna, Vienna
Otto Wagner Spital, Vienna
Policlinico Universitario Agostino Gemelli, Rome
SEAMEO Regional Centre for Tropical Medicine, Antwerp
University Hospital of Leuven, Leuven
Hospital del Mar, Barcelona
Aaron Diamond AIDS Research Center, New York
Greiger Clinic, Mount Vernon
EPIMED GmbH, Berlin
MIB Dienstleistung GmbH, Berlin
Hospital Clinico Universitario de Santiago, Santiago de Compostela
Philadelphia FIGHT, Philadelphia
Dupont Circle Physicians Group, P.C., Washington D.C.
Capital Medical Associates, P.C., Washington D.C.
Fondazione Centro San Raffaele del Monte Tabor, Milan
ICH Study Center, Hamburg
Ospedale Luigi Sacco, Milan
Azienda Ospedaliera Ospedale di Circolo Busto Arsizio, Busto Arsizio/Varese
Clinical Alliance for Research & Education - Infectious Disease, Annandale
CHU de Besancon - Hopital Saint-Jacques, Besançon
Wake Forest University Health Sciences, Winston-Salem
Hospital General Universitario Gregorio Maranon, Madrid
ID Consultants, P.A., Charlotte
Infectious Disease Specialists of Atlanta, Decatur
Atlanta ID Group, PC, Atlanta
Infectious Diseases Associates of Northwest Florida, Pensacola
Orlando Immunology Center, Orlando
ValuHealth MD, LLC, Orlando
Groupe Hospitalier Pellegrin, Bordeaux
The Kinder Medical Group, Miami
Gary Richmond MD, PA, Inc, Fort Lauderdale
Health Positive, Safety Harbor
Midway Immunology and Research, Ft. Pierce
Hospital La Fe de Valencia, Valencia
Be Well Medical Center, Berkley
Medizinische Universitätsklinik, Bonn
HIV Program Hennepin County Medical Center, Minneapolis
Infektiologikum, Frankfurt
The Kansas City Free Health Clinic, Kansas City
Hopital Saint Louis, Paris
Hopital Bichat Claude Bernard, Paris
Southwest Infectious Disease Clinical Researach Inc, Dallas
Hopital Saint Antoine, Paris
Tarrant County Infectious Disease Associates, Fort Worth
Therapeutic Concepts PA, Houston
Gordon E. Crofoot MD, PA, Houston
Universitatsklinikum Freiburg, Freiburg im Breisgau
MUC Research GmbH, München
Spectrum Medical Group, Phoenix
Peter J. Ruane, MD, Inc., Los Angeles
OASIS Clinic, Los Angeles
Anthony Mills MD Inc, Los Angeles
AHF Research Center, Beverly Hills
Pacific Oak Medical Group, Beverly Hills
La Playa Medical Group and Clinical Research, San Diego
Metropolis Medical, San Francisco
Kaiser Permanente, San Francisco
Kaiser Permanente, Hayward
Alameda County Medical Center, Oakland
Kaiser Permanente Medical Group, Sacramento
ID Care, Hillsborough
Saint Michael's Medical Center, Newark
South Jersey Infectious Disease, Somers Point
Holdsworth House Medical Practice, Darlinghurst
East Sydney Doctors, Sydney
Prahran Market Clinic, South Yarra
Sunnybrook Health Sciences Center, Toronto
Maple Leaf Medical Clinic, Toronto
Clinique Medicale Du Quartier Latin, Montreal
"Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS", Roma
Hospital de Santa Maria - CHLN EPE, Lisbon
Clinical Research Puerto Rico Inc, San Juan
Hospital de la Santa Creu i Sant Pau, Barcelona
Brighton and Sussex University Hospitals NHS Trust, Brighton
Western General Hospital, Edinburgh
Homerton University Hospital, London
South London Healthcare NHS Trust, London
St. Thomas' Hospital, London
Chelsea & Westminster Hospital, London
Lead Sponsor
Gilead Sciences
INDUSTRY